The FDA's Office of New Drugs reorganization, which includes creation of a new Office of Rare Diseases, Pediatrics and Women's Health, also remains on track. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
